Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.51 |
| ▸ | MAPT | P10636 | 6/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | FDPS | P14324 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.41 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16471789 | 0.85 | TACR2 (0.37) | TACR2ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL16459820 | 0.79 | FDPS (0.52) | ALDH1A1MAPTFDPSKDM4ELMNA | |
| SCHEMBL16459818 | 0.79 | FDPS (0.52) | ALDH1A1MAPTFDPSKDM4ELMNA | |
| SCHEMBL16460041 | 0.76 | NFE2L2 (0.64) | ALDH1A1MAPTMEN1KMT2AFDPS | |
| SCHEMBL582919 | 0.76 | KDM4E (0.64) | ALDH1A1KDM4ESMN1; SMN2HPGD | |
| SCHEMBL582918 | 0.76 | KDM4E (0.64) | ALDH1A1KDM4ESMN1; SMN2HPGD | |
| SCHEMBL28164564 | 0.75 | HTT (0.52) | ALDH1A1KDM4EHTTRAB9ATSHR | |
| SCHEMBL583609 | 0.73 | FDPS (0.69) | ALDH1A1MAPTFDPSKDM4ENPC1 | |
| SCHEMBL583610 | 0.73 | FDPS (0.69) | ALDH1A1MAPTFDPSKDM4ENPC1 | |
| SCHEMBL13143814 | 0.73 | FDPS (0.69) | ALDH1A1MAPTFDPSKDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140011813-A1 | Medicine for Treating Ischemic Brain Injury and its Sequelae, and Preparation Method Thereof | HAIMIN LEI (CN) | 2014-01-09 | — | — | US | claimed |
| US-8987449-B2 | Medicine for treating ischemic brain injury and its sequelae, and preparation method thereof | HAIMIN LEI (CN) | 2015-03-24 | — | — | US | disclosed |
| US-8987449-B2 | Medicine for treating ischemic brain injury and its sequelae, and preparation method thereof | HAIMIN LEI (CN) | 2015-03-24 | — | — | US | disclosed |
| US-8987449-B2 | Medicine for treating ischemic brain injury and its sequelae, and preparation method thereof | HAIMIN LEI (CN) | 2015-03-24 | — | — | US | disclosed |
| US-20140011813-A1 | Medicine for Treating Ischemic Brain Injury and its Sequelae, and Preparation Method Thereof | HAIMIN LEI (CN) | 2014-01-09 | — | — | US | disclosed |
| US-20140011813-A1 | Medicine for Treating Ischemic Brain Injury and its Sequelae, and Preparation Method Thereof | HAIMIN LEI (CN) | 2014-01-09 | — | — | US | disclosed |
| US-20140011813-A1 | Medicine for Treating Ischemic Brain Injury and its Sequelae, and Preparation Method Thereof | HAIMIN LEI (CN) | 2014-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140011813-A1 | Medicine for Treating Ischemic Brain Injury and its Sequelae, and Preparation Method Thereof | FABP7, FABP3, FLT4 | TACR2 724/4885ALDH1A1 88/4885MAPT 3694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.